Reply

摘要

We are thankful for the profound comments of Wu and colleagues. Our study was, indeed, only a very small feasibility trial to evaluate the safety and efficacy of the 30-cm-long Proteus Embolic Capture Angioplasty (ECA) balloon; it was clearly not a clinical endpoint study.